W STRATEGIES, LLC

Lobbying for MERCK & CO., INC. · Pharmaceutical Company.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · $50,000.00 income · posted Oct 20, 2025

Bills named in this filing 1

HR 1492
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic can…

Lobbying activity 1

Medicare/Medicaid

Public Law 119-21: One Big Beautiful Bill Act. H.R.1492: EPIC Act. Education around access to vaccines.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.